Energy_intake

Semaglutide-Induced Weight Loss Does Not Impair Muscle Function and Improves Endurance Running Capacity in Obese Mice.

BACKGROUND

Semaglutide, a member of the glucagon-like peptide-1 receptor agonists, induces substantial weight loss, primarily through appetite suppression and reduced energy intake. In addition to fat mass reduction, a considerable loss of lean body mass is also observed. How these effects...

🗓️ 2026-11-17
📰 Publication: Journal Of Cachexia Sarcopenia And Muscle
Read MoreSemaglutide-Induced Weight Loss Does Not Impair Muscle Function and Improves Endurance Running Capacity in Obese Mice.

Subscribe to the SCWD Newsletter

Stay Informed with the Latest Updates and Exclusive Insights!